1. Home
  2. SLNO vs TFSL Comparison

SLNO vs TFSL Comparison

Compare SLNO & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • TFSL
  • Stock Information
  • Founded
  • SLNO 1999
  • TFSL 1938
  • Country
  • SLNO United States
  • TFSL United States
  • Employees
  • SLNO N/A
  • TFSL N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TFSL Savings Institutions
  • Sector
  • SLNO Health Care
  • TFSL Finance
  • Exchange
  • SLNO Nasdaq
  • TFSL Nasdaq
  • Market Cap
  • SLNO 3.8B
  • TFSL 3.9B
  • IPO Year
  • SLNO 2014
  • TFSL 2007
  • Fundamental
  • Price
  • SLNO $62.37
  • TFSL $13.57
  • Analyst Decision
  • SLNO Strong Buy
  • TFSL Hold
  • Analyst Count
  • SLNO 9
  • TFSL 1
  • Target Price
  • SLNO $116.78
  • TFSL $15.00
  • AVG Volume (30 Days)
  • SLNO 2.7M
  • TFSL 428.8K
  • Earning Date
  • SLNO 11-05-2025
  • TFSL 10-29-2025
  • Dividend Yield
  • SLNO N/A
  • TFSL 8.30%
  • EPS Growth
  • SLNO N/A
  • TFSL 3.58
  • EPS
  • SLNO N/A
  • TFSL 0.29
  • Revenue
  • SLNO $32,656,999.00
  • TFSL $308,625,000.00
  • Revenue This Year
  • SLNO N/A
  • TFSL $7.25
  • Revenue Next Year
  • SLNO $181.85
  • TFSL $7.66
  • P/E Ratio
  • SLNO N/A
  • TFSL $46.93
  • Revenue Growth
  • SLNO N/A
  • TFSL 1.03
  • 52 Week Low
  • SLNO $41.50
  • TFSL $11.29
  • 52 Week High
  • SLNO $90.32
  • TFSL $15.00
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 48.83
  • TFSL 58.41
  • Support Level
  • SLNO $55.78
  • TFSL $13.01
  • Resistance Level
  • SLNO $68.46
  • TFSL $13.29
  • Average True Range (ATR)
  • SLNO 4.12
  • TFSL 0.23
  • MACD
  • SLNO 0.71
  • TFSL 0.03
  • Stochastic Oscillator
  • SLNO 67.58
  • TFSL 72.84

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

Share on Social Networks: